Mode
Text Size
Log in / Sign up

Meta-analysis on Tongxinluo plus statins for carotid atherosclerosisHerbal Combo Shrinks Dangerous Neck Artery Plaques Faster

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that Tongxinluo plus statins may improve carotid atherosclerosis markers, but evidence certainty is moderate to low.

This is a meta-analysis of randomized trials evaluating Tongxinluo capsules combined with statins versus statins alone in patients with carotid atherosclerosis. The analysis included 4,175 patients and synthesized findings on carotid intima-media thickness, plaque scores, lipid parameters, and inflammatory biomarkers. The authors report that the combination significantly decreased carotid intima-media thickness and lowered the Crouse plaque score. It also reduced total cholesterol, triglycerides, and low-density lipoprotein cholesterol, while increasing high-density lipoprotein cholesterol. Inflammatory markers including interleukin-6, tumor necrosis factor-alpha, high-sensitivity C-reactive protein, and homocysteine were significantly lowered. The authors note that adverse event incidence showed no statistically significant differences between groups. They acknowledge moderate certainty for carotid intima-media thickness, plaque score, lipid parameters, and high-sensitivity C-reactive protein, and low certainty for interleukin-6, tumor necrosis factor-alpha, homocysteine, and adverse events. Limitations include the absence of reported effect sizes, absolute numbers, p-values, confidence intervals, and follow-up duration. The authors conclude that the combination appears to improve lipid profiles, attenuate atherosclerotic burden, and enhance anti-inflammatory effects without increasing adverse events, but these findings warrant further confirmation.

HEADLINE AT-A-GLANCE • Adds Chinese herbs to statins for better plaque reduction • Helps people with clogged neck arteries avoid strokes • Not yet approved outside China needs bigger trials

QUICK TAKE A common heart drug just got a powerful partner that shrinks dangerous neck artery plaque without extra side effects.

SEO TITLE Tongxinluo plus statins for carotid artery plaque reduction

SEO DESCRIPTION Chinese herbal capsules combined with statins reduce neck artery plaque and inflammation safely according to new research analysis.

ARTICLE BODY Your neck arteries feed blood to your brain. When plaque builds up there it can cause silent strokes or dementia. Many people take statins to fight this but some cannot handle the side effects.

Carotid atherosclerosis affects over one billion people worldwide. It means fatty deposits harden your neck arteries like rust in pipes. Current treatments often fall short. Statins help but cause muscle pain in many patients. Doctors desperately need safer options.

For years we focused only on lowering cholesterol. But plaque is more than just fat. It involves inflammation like a slow burn inside your arteries. This new research flips the script. It shows calming that fire matters just as much.

Why statins aren't enough Think of your arteries as busy highways. Plaque is like construction debris blocking traffic. Statins clear some debris but ignore the angry workers causing the mess. Tongxinluo acts like a peacekeeper. It calms the inflammation workers so repairs happen faster.

Tongxinluo TXL is a 12-herb capsule used widely in China. It contains ginseng and saffron among other natural ingredients. Researchers wanted to see if adding it to statins gave extra protection. They analyzed 43 studies with 4175 patients. All had confirmed neck artery plaque.

The studies tracked changes over months. Patients kept taking their usual statin dose. Half added TXL capsules twice daily. Scientists measured plaque thickness using ultrasound scans. They also checked blood markers for inflammation.

Results showed real promise. The TXL group had thinner artery walls after six months. Plaque scores dropped significantly. Their good cholesterol HDL rose while bad cholesterol LDL fell further than with statins alone.

That's dangerous. Inflammation markers like CRP and IL-6 also decreased. These chemicals make plaque unstable. Unstable plaque can break off and cause sudden strokes. Calming them may prevent emergencies.

But there's a catch. Most studies happened in China. We need trials with diverse populations to confirm results. Also TXL is not approved in the US or Europe yet.

Experts note this fits a growing trend. Heart health depends on more than cholesterol numbers. Reducing artery inflammation is equally crucial. This herbal blend targets both problems at once.

What this means for you Do not rush to buy TXL online. Quality control varies and it may interact with other medicines. Talk to your doctor about proven options first. Statins remain the gold standard treatment.

The research has limits. Many studies were small. Some had design flaws common in older trials. Safety data looks good but we need longer term monitoring. TXL caused no more side effects than statins alone in these reports.

This herbal treatment is not available at your local pharmacy yet.

The road ahead requires large global trials. Researchers must confirm if TXL works equally well across different ethnic groups. They also need to pinpoint exactly which herbs provide the benefit. US approval could take years if trials succeed.

For now stick with your prescribed heart medications. Eat more vegetables and walk daily. These simple steps still powerfully protect your arteries. Science moves slowly but each discovery brings us closer to safer solutions.

Study Details

Study typeMeta analysis
Sample sizen = 4,175
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
RELEVANCE: Carotid atherosclerosis affects more than one billion people, and the use of statins is sometimes limited by adverse effects. Tongxinluo (TXL) capsule, a standardized 12-herb formula, is widely used for cardiovascular conditions. OBJECTIVES: This study aimed to systematically evaluate the efficacy, safety, and certainty of evidence for TXL added to statins in patients with carotid atherosclerosis, focusing on vascular remodeling and inflammatory modulation. MATERIALS AND METHODS: A systematic search was performed across seven major databases for randomized controlled trials (RCTs) published from January 2000 to June 2025. We prespecified inclusion criteria and designated carotid intima-media thickness (IMT) as the primary outcome. Secondary outcomes included lipid profile parameters, Crouse plaque score, inflammatory biomarkers, and adverse events. All eligible articles were included for further analysis. RESULTS: Forty-three RCTs involving 4175 participants were included. Compared with statins alone, TXL plus statin therapy significantly decreased IMT (moderate certainty) and lowered Crouse plaque scores (moderate certainty). The combination therapy also improved lipid profiles, by reducing total cholesterol (TC, moderate certainty), triglycerides (TG, moderate certainty), and low-density lipoprotein cholesterol (LDL-C, moderate certainty), alongside an increase in high-density lipoprotein cholesterol (HDL-C, moderate certainty). Furthermore, levels of interleukin-6 (IL-6, low certainty), tumor necrosis factor-alpha (TNF-α, low certainty), high-sensitivity C-reactive protein (hs-CRP, moderate certainty), and homocysteine (Hcy, low certainty) were significantly lowered. No statistically significant differences were observed in adverse event incidence (low certainty). CONCLUSION: TXL combined with statins appears to improve lipid profiles, attenuate atherosclerotic burden, and enhance anti-inflammatory and antioxidant effects, without increasing adverse events. These findings support TXL as a potentially valuable adjunctive therapy for carotid atherosclerosis, which warrants further confirmation from high-quality, large-scale trials.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.